Breaks Categories: News

WednesdayApr 17, 2024 2:16 pm

NetworkNewsBreaks – Clene Inc. (NASDAQ: CLNN) Announces Study Results for CNM-Au8 as Multiple Sclerosis Treatment Presented at AAN Conference

Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company, and its wholly owned subsidiary Clene Nanomedicine Inc., announced that results from a phase 2 Visionary-MS long-term extension (“LTE”) study have been presented at the 2024 American Academy of Neurology (“AAN”) annual meeting. The data, which demonstrates improved clinical, functional and structural outcomes associated with daily oral dosing of CNM-Au8 30 mg. for up to three years of treatment, was presented by Dr. Michael Barnett, MBBS, FRACP, FRCP, PhD, from the University of Sydney. The new long-term results from the clinical trial indicate the repair and remyelinating effects of CNM-Au8 treatment in…

Continue Reading

WednesdayApr 17, 2024 1:42 pm

NetworkNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) in Process of Responding to Emergency Request for IV Suramin from African Health Ministry

PaxMedica (NASDAQ: PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, has received an urgent request from the Ministry of Health (“MOH”) of Malawi requesting emergency access to IV suramin. According to the announcement, Malawi officials requested the suramin in efforts to avert a potential humanitarian crisis brought on by dwindling supplies of drugs used in that region of Africa; the drug is used specifically to treat the most severe form of African sleeping sickness. Last week, PaxMedica completed execution of its three pivotal registration/validation batches of PAX-101 (an IV form of suramin) in preparation for a future…

Continue Reading

WednesdayApr 17, 2024 1:06 pm

NetworkNewsBreaks – Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF) (FSE: A0I0) Files NI 43-101 Technical Report for Goiás-Based PCH Ionic Adsorption Clay Project

  Appia Rare Earths & Uranium (CSE: API) (OTCQX: APAAF) (FSE: A0I0), a publicly traded Canadian company in the rare earth element and uranium sectors, has filed an independent technical report for its PCH ionic adsorption clay (“IAC”) project located in Goiás, Brazil. The PCH MRE report was prepared in accordance with National Instrument 43-10 (“NI 43-101”). Titled “Technical Report on the Maiden Mineral Resource Estimate for the PCH Project, State of Goiás, Brazil,” the report indicated no material differences from results disclosed in the company’s press release released last month. The company noted that the report was coauthored by independent…

Continue Reading

TuesdayApr 16, 2024 4:39 pm

NetworkNewsBreaks – SOBR Safe Inc. (NASDAQ: SOBR) CEO Featured in Inaugural Video Release from Lytham Spotlight Series

SOBRsafe (NASDAQ: SOBR), providers of next-generation, transdermal alcohol-detection solutions, was spotlighted in the first episode of the Lytham Spotlight Series, a series of interview designed to “shine a light on public companies from a variety of sectors though insightful interviews and exclusive updates.” During the video, SOBRsafe CEO Dave Gandini talked with Roger Weiss, a vice president at Lytham Partners, about SOBRsafe’s evolved sales focus and 2024 strategy. Gandini summarized progress that the company has made, includinguplisting from the OTC to NASDAQ and then exploring the best markets for SOBRsafe to focus on. He noted that initially the company targeted…

Continue Reading

TuesdayApr 16, 2024 4:03 pm

NetworkNewsBreaks – Turbo Energy S.A. (NASDAQ: TURB) Portable GoSolar Solution Now Available at Largest Department Store Chain in Europe

Turbo Energy S.A. (NASDAQ: TURB), a leader in the field of photovoltaic energy storage, announced that its GoSolar portable solar-energy storage solution will now be offered for sale at El Corte Inglés S.A., the largest department store group in Europe. According to the announcement, the launch of the GoSolar system represents El Corte Inglés S.A.’s commitment to innovation and sustainability. The department store chain is the only remaining department store chain in Spain and Portugal. The company has built a reputation for offering a wide range of products, including music, movies, portable and household electronics, furniture, hardware, books, clothes, groceries,…

Continue Reading

TuesdayApr 16, 2024 3:46 pm

NetworkNewsBreaks – Vape South America Medellín 2024 to Showcase Innovation in Alternative Products Supply Chain

Alternative Products Expo has announced the return of the world’s premier counterculture industry event to Medellín, Colombia. Another first-class production of ZJ Events, Vape South America Medellín 2024 is slated to take place at the Centro de Convenciones Plaza Mayor in Medellín from May 18-19, 2024. Strategically located with a welcoming atmosphere and great climate, the Vape South America Medellín 2024 has become a prime gateway between the U.S. and South American markets and offers a unique opportunity to establish connections with buyers and distributors from around the globe. “Vape South America Medellín 2024 is a globally renowned platform in…

Continue Reading

TuesdayApr 16, 2024 3:41 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Receives Approval to Commence Human Pilot Study Evaluating GLP-1, DehydraTECH

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, has received approval to begin a new human pilot study. The approval, which was granted by an independent third-party ethics review board, enables Lexaria to move forward with its plan to conduct a GLP-1 study investigating GLP-1 drugs and DehydraTECH(TM). According to the announcement, subject recruitment will begin immediately with the first dosing expected within the next month; the company plans to complete the study this summer. The study will be comprised of two study arms and will include up to nine healthy volunteers. The study is designed to…

Continue Reading

TuesdayApr 16, 2024 3:04 pm

NetworkNewsBreaks – Bebuzee Inc. (BBUZ) Prepares to Launch Game-Changing Super App, Engages IBN for Corporate Communications Expertise

Bebuzee (OTC: BBUZ), a pioneer in the social platform and streaming service industry, today announced that it is moving beyond its beta phase and is now gearing up for the official launch of its Super App. Poised to be the first Super App in America and Europe, Bebuzee is set to revolutionize the digital world by offering a comprehensive and seamless solution that integrates multiple services into a single platform. “The Bebuzee Super App is not just an app; it’s a revolution. We’re about to change the game by offering a comprehensive digital ecosystem that caters to every user’s needs,…

Continue Reading

TuesdayApr 16, 2024 2:17 pm

NetworkNewsBreaks – Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF) (FSE: A0I0) (MUN: A0I0) (BER: A0I0) Announces Engagement of Generation IACP

Appia (CSE: API) (OTCQX: APAAF) (FSE: A0I0) (MUN: A0I0) (BER: A0I0) today announced that it has engaged Generation IACP Inc. (“IACP”) to provide services as a market maker in compliance with the policies and guidelines of the Canadian Securities Exchange and other applicable legislation. According to the announcement, IACP will receive a fee of C$7,500 plus applicable taxes per month under the agreement, which is for an initial term of six months. The agreement shall be automatically renewed for subsequent six month periods (collectively, the “term’) unless the company provides written notice of termination to IACP at least 30 days…

Continue Reading

TuesdayApr 16, 2024 1:32 pm

NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports on Promising Results from Study on INM-089 Treatment of Dry AMD

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids and proprietary cannabinoid analogs, is reporting on additional preclinical data for INM-089, a proprietary small molecule compound acting as a preferential signaling ligand of cannabinoid receptor 1 (“CB1”) and cannabinoid receptor 2 (“CB2”). The reported data continues to demonstrate positive pharmacological effects in the treatment of dry age-related macular degeneration (“AMD”). According to the announcement, in vivo preclinical studies in AMD disease models show that INM-089 delivers improved retinal pigment epithelium integrity, neuroprotection and photoreceptor improvement. Earlier results showed that INM-089 also preserved retinal function…

Continue Reading